According to CTI BioPharma 's latest financial reports the company's current EPS (TTM) is -$0.92. In 2022 the company made an earnings per share (EPS) of -$1.35 an increase over its 2021 EPS that were of -$1.72.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.86 | -36.37% |
2022 | -$1.35 | -21.3% |
2021 | -$1.72 | 45.95% |
2020 | -$1.18 | 7.25% |
2019 | -$1.10 | 30.19% |
2018 | -$0.84 | -58.91% |
2017 | -$2.05 | -29.12% |
2016 | -$2.89 | -72.84% |
2015 | -$10.65 | 6.35% |
2014 | -$10.01 |